N-acetyl-L-leucine: a promising treatment option for traumatic brain injury

被引：0

作者：

Chinmoy Sarkar ^{[1
]}

Marta M.Lipinski ^{[1
,2
]}

机构：

[1] Shock,Trauma and Anesthesiology Research (STAR)Center,Department of Anesthesiology,University of Maryland School of Medicine

[2] Department of Anatomy and Neurobiology,University of Maryland School of Medicine

来源：

Neural Regeneration Research | 2022年 / 17卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R651.15 [];

学科分类号：

摘要：

Traumatic brain injury (TBI) is a mechanical injury to the brain,which can be sustained due to falls,accidents,contact sports or in combat situation.It is a serious health problem-affecting people of all ages worldwide.As per the recent epidemiological study,more than 55 million people suffer from TBI annually (GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators,

引用

页码：1957 / 1958

页数：2

共 50 条

[31] Endocannabinoids: A Promising Impact for Traumatic Brain Injury
Schurman, Lesley D.
Lichtman, Aron H.
FRONTIERS IN PHARMACOLOGY, 2017, 8
[32] Decompressive craniectomy is an efficient treatment option for traumatic brain injury: Our experience
Bunc, Gorazd
Ravnik, Janez
Klobucar, Robert
Velnar, Tomaz
BRAIN INJURY, 2014, 28 (5-6) : 608 - 608
[33] Normobaric hyperoxia - A further treatment option following traumatic brain injury? Reply
Nortje, Jurgens
Coles, Jonathan P.
Menon, David K.
CRITICAL CARE MEDICINE, 2008, 36 (05) : 1698 - 1698
[34] Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat Brain
Scafidi, Susanna
Racz, Jennifer
Hazelton, Julie
McKenna, Mary C.
Fiskum, Gary
DEVELOPMENTAL NEUROSCIENCE, 2010, 32 (5-6) : 480 - 487
[35] N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
T Fields
T M. Bremova
I Billington
GC Churchill
W Evans
C Fields
A Galione
R Kay
T Mathieson
K Martakis
M Patterson
F Platt
M Factor
M Strupp
Trials, 24
[36] Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-pick disease type C
Strupp, Michael
Bremova-Ertl, Tatiana
Fields, Taylor
Factor, Mallory
Martakis, Kyriakos
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[37] Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
Fields, Taylor
Bremova-Ertl, Tatiana
Ramaswami, Uma
Brands, Marion
Gautschi, Matthias
Gissen, Paul
Hahn, Andreas
Jones, Simon
Kolnikova, Miriam
Arash-Karps, Laila
Mengel, Eugen
Park, Julien
Reichmannova, Stella
Schneider, Susanne
Sivananthan, Siyamini
Walterfang, Mark
Wibawa, Pierre
Strupp, Michael
Martakis, Kyriakos
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[38] N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study
Fields, T.
M. Bremova, T.
Billington, I
Churchill, G. C.
Evans, W.
Fields, C.
Galione, A.
Kay, R.
Mathieson, T.
Martakis, K.
Patterson, M.
Platt, F.
Factor, M.
Strupp, M.
TRIALS, 2023, 24 (01)
[39] Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial
Beyraghi-Tousi, Mehran
Sahebkar, Amirhosein
Houra, Mahsa
Sarvghadi, Pooria
Jamialahmadi, Tannaz
Bagheri, Reza
Tavallaie, Shima
Gumpricht, Eric
Saberi-Karimian, Maryam
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2024, 50 : 57 - 63
[40] AQUEOUS-SOLUTIONS CONTAINING AMINO-ACIDS AND PEPTIDES .11. ENTHALPY OF DILUTION OF SINGLE AND BINARY SOLUTE SOLUTIONS OF N-ACETYL-GLYCINE AMIDE, N-ACETYL-L-ALANINE AMIDE, N-ACETYL-L-VALINE AMIDE AND N-ACETYL-L-LEUCINE AMIDE AT 298.15-K
BLACKBURN, GM
LILLEY, TH
WALMSLEY, E
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1980, 76 : 915 - 922

← 1 2 3 4 5 →